Analytical Data
-
Gene name
LAB7-1
- Application
-
Alternative Names
LAB7-1；CD28LG；CD28LG1；LAB7；T-lymphocyte activation antigen CD80
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P33681
-
Expression Region
35-242aa
-
AA Sequence
VIHVTKEVKEVATLSCGHNVSVEELAQTRIYWQKEKKMVLTMMSGDMNIW PEYKNRTIFDITNNLSIVILALRPSDEGTYECVVLKYEKDAFKREHLAEV TLSVKADFPTPSISDFEIPT SNIRRIICSTSGGFPEPHLSWLENGEEL NAINTTVSQDPETELYAVSSKLDFNMTTNHSF MCLIKYGHLRVNQTFN WNTTKQEHFPDN
-
Molecular Weight
50 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LAB7-1 is a recombinant protein that has garnered attention in the field of biotechnology and molecular biology due to its potential applications in therapeutics, diagnostics, and research. The study of LAB7-1 is rooted in the growing demand for innovative protein-based solutions to address various health challenges, including infectious diseases and cancer. Recombinant proteins, produced by genetically engineered organisms, offer several advantages over traditional methods of protein extraction, such as improved yield, purity, and the ability to incorporate specific modifications. LAB7-1 serves as a model to explore the intricacies of protein folding, stability, and activity, which are crucial for developing effective biopharmaceuticals. Additionally, understanding LAB7-1's structure and function can facilitate the development of vaccines or targeted therapies, particularly in the context of emerging pathogens. The ongoing research on LAB7-1 not only aims to elucidate its biological role but also to optimize its production and enhance its therapeutic potential, underscoring the crucial intersection of molecular genetics and protein engineering in contemporary biomedical research. As advancements in recombinant DNA technology and protein expression systems continue to evolve, LAB7-1 stands at the forefront of exploration, offering insights that may lead to significant breakthroughs in medical science.
